TREATMENT OF MYELOSUPPRESSION
- 专利权人:
- Cantex Pharmaceuticals; Inc.
- 发明人:
- Stephen Marcus
- 申请号：
- US15923470
- 公开号：
- US20180296590A1
- 申请日:
- 2018.03.16
- 申请国别(地区):
- US
- 年份:
- 2018
- 代理人:
- 摘要：
- Methods are presented for attenuating myelosuppressive side effects of treatment regimens, promoting thrombopoiesis and neutrophil production, and increasing efficacy of treatment regimens, by administering PF4-interacting heparinoids.
- 来源网站：
- 中国工程科技知识中心
